Skin Clearance and Itch Relief in Black or African American Patients with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s615, 2025. DOI: 10.25251/9qs79351. Disponível em: https://skin.dermsquared.com/skin/article/view/3873. Acesso em: 20 apr. 2026.